"10.1371_journal.pgen.1002548","plos genetics","2012-03-15T00:00:00Z","Christina M Lill; Johannes T Roehr; Matthew B McQueen; Fotini K Kavvoura; Sachin Bagade; Brit-Maren M Schjeide; Leif M Schjeide; Esther Meissner; Ute Zauft; Nicole C Allen; Tian Liu; Marcel Schilling; Kari J Anderson; Gary Beecham; Daniela Berg; Joanna M Biernacka; Alexis Brice; Anita L DeStefano; Chuong B Do; Nicholas Eriksson; Stewart A Factor; Matthew J Farrer; Tatiana Foroud; Thomas Gasser; Taye Hamza; John A Hardy; Peter Heutink; Erin M Hill-Burns; Christine Klein; Jeanne C Latourelle; Demetrius M Maraganore; Eden R Martin; Maria Martinez; Richard H Myers; Michael A Nalls; Nathan Pankratz; Haydeh Payami; Wataru Satake; William K Scott; Manu Sharma; Andrew B Singleton; Kari Stefansson; Tatsushi Toda; Joyce Y Tung; Jeffery Vance; Nick W Wood; Cyrus P Zabetian; 23andMe, The Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium; The International Parkinson's Disease Genomics Consortium (IPDGC); The Parkinson's Disease GWAS Consortium; The Wellcome Trust Case Control Consortium 2 (WTCCC2); Peter Young; Rudolph E Tanzi; Muin J Khoury; Frauke Zipp; Hans Lehrach; John P A Ioannidis; Lars Bertram","Neuropsychiatric Genetics Group, Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America; Department of Neurology, Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Department of Neurology, University Hospital, Münster, Germany; Department of Mathematics and Computer Science, Free University, Berlin, Germany; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, United States of America; Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Centre for Diabetes and Endocrinology, Royal Berkshire Hospital, Reading, United Kingdom; Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, University of Oxford, Oxford, United Kingdom; Max Planck Institute for Human Development, Berlin, Germany; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America; Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany; INSERM, UMR_S975, Paris, France; Université Pierre et Marie Curie-Paris, Centre de Recherche de lInstitut du Cerveau et de la Moelle épinière, UMR-S975, Paris, France; CNRS, UMR 7225, Paris, France; AP-HP, Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France; Department of Neurology, Boston University School of Medicine, Boston University, Boston, Massachusetts, United States of America; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America; 23andMe, Mountain View, California, United States of America; Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, United States of America; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; Indiana University School of Medicine, Indianapolis, Indiana, United States of America; New York State Department of Health Wadsworth Center, Albany, New York, United States of America; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom; Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, The Netherlands; Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lübeck, Lübeck, Germany; Department of Neurology, NorthShore University Health System, Evanston, Illinois, United States of America; INSERM UMR 1043, CPTP, Toulouse, France; Paul Sabatier University, Toulouse, France; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America; Division of Neurology/Molecular Brain Science, Kobe University Graduate School of Medicine, Kobe, Japan; deCODE genetics, Reykjavik, Iceland; UCL Genetics Institute, University College London, London, United Kingdom; Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom; VA Puget Sound Health Care System and Department of Neurology, University of Washington, Seattle, Washington, United States of America; Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; Biomedical Research Institute, Foundation for Research and Technology–Hellas, Ioannina, Greece; Center for Genetic Epidemiology and Modeling and Tufts Clinical and Translational Science Institute, Tufts University School of Medicine, Boston, Massachusetts, United States of America; Stanford Prevention Research Center, Department of Medicine and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America","Conceived and designed the experiments: CM Lill, MB McQueen, JPA Ioannidis, L Bertram. Performed the experiments: CM Lill, JT Roehr, S Bagade, B-M Schjeide, E Meissner, U Zauft, NC Allen, KJ Anderson, G Beecham, D Berg, JM Biernacka, A Brice, AL DeStefano, CB Do, N Eriksson, SA Factor, MJ Farrer, T Foroud, T Gasser, T Hamza, JA Hardy, P Heutink, C Klein, JC Latourelle, DM Maraganore, ER Martin, M Martinez, RH Myers, H Payami, WK Scott, M Sharma, AB Singleton, K Stefansson, T Toda, JY Tung, J Vance, NW Wood, CP Zabetian, 23andMe, GEO-PD, IPDGC, Parkinsons Disease GWAS, WTCC2. Analyzed the data: CM Lill, JT Roehr, MB McQueen, FK Kavvoura, L Bertram. Wrote the paper: CM Lill, JPA Ioannidis, L Bertram. Helped write the manuscript: E Meissner, MJ Farrer, T Foroud, T Gasser, C Klein, DM Maraganore, H Payami, AB Singleton, M Sharma, F Zipp, H Lehrach. Helped analyze the data: S Bagade, T Liu, M Schilling, CB Do, N Eriksson, T Hamza, EM Hill-Burns, MA Nalls, N Pankratz, W Satake, M Sharma. Interpretation of results: CM Lill, JPA Ioannidis, L Bertram. Study coordination: CM Lill, T Foroud, JA Hardy, H Payami, AB Singleton, P Young, RE Tanzi, MJ Khoury, F Zipp, H Lehrach, JPA Ioannidis, L Bertram. Literature searches and data entry: CM Lill, S Bagade, B-M Schjeide, E Meissner, U Zauft, N Allen.","CB Do, N Eriksson, and JY Tung are employed by 23andMe and own stock options in the company. MJ Farrer and Mayo Foundation received royalties from H.Lundbeck A/S and Isis Pharmaceuticals. In addition, MJ Farrer has received an honorarium for a seminar at Genzyme. T Gasser has received consultancy fees from Cephalon and Merck-Serono, grants from Novartis, payments for lectures including service on speakers bureaus from Boehringer Ingelheim, Merck-Serono, UCB, and Valean, and holds patents NGFN2 and KASPP. JA Hardy has received consulting fees or honoraria from Eisai and his institute has received consulting fees or honoraria from Merck-Serono. DM Maraganore has received extramural research funding support from the National Institutes of Health (2R01 ES10751), the Michael J. Fox Foundation (Linked Efforts to Accelerate Parkinson Solutions Award, Edmond J. Safra Global Genetics Consortia Award), and from Alnylam Pharmaceuticals and Medtronic (observational studies of Parkinsons disease). DM Maraganore has also received intramural research funding support from the Mayo Clinic and from NorthShore University Health System. DM Maraganore filed a provisional patent for a method to predict Parkinsons disease. This provisional patent is unlicensed. He also filed a provisional patent for a method to treat neurodegenerative disorders. That provisional patent has been licensed to Alnylam Pharmaceuticals and DM Maraganore has received royalty payments in total of less than $20,000. K Stefansson has received grants from deCODE.","2012","03","Christina M Lill","CML",58,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
